Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Age-Associated Memory Impairment
NCT00267163Phase 4Completed
- Sponsor
- National Institute on Aging
- Start
- Sep 2000
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Age-associated memory impairment (AAMI) comparing Donepezil with Placebo (2 arms). Primary endpoint: Changes in cognition and brain metabolism measured by PET and MRI scans, and neuropsychological testing at 18 months. Started Sep 2000; status: completed.
02
Drugs
donepezil
03
Conditions
Age-associated memory impairment (AAMI)
Beyond the preview
Go deeper on NCT00267163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267163.